These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 32010404)

  • 21. PTEN gene mutations correlate to poor prognosis in glioma patients: a meta-analysis.
    Han F; Hu R; Yang H; Liu J; Sui J; Xiang X; Wang F; Chu L; Song S
    Onco Targets Ther; 2016; 9():3485-92. PubMed ID: 27366085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The association of Phosphatase and tensin homolog (PTEN) deletion and prostate cancer risk: A meta-analysis.
    Gao T; Mei Y; Sun H; Nie Z; Liu X; Wang S
    Biomed Pharmacother; 2016 Oct; 83():114-121. PubMed ID: 27470558
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loss of phosphatase and tensin homolog expression correlates with clinicopathological features of non-small cell lung cancer patients and its impact on survival: A systematic review and meta-analysis.
    Zhao Y; Zheng R; Li J; Lin F; Liu L
    Thorac Cancer; 2017 May; 8(3):203-213. PubMed ID: 28263037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of PTEN in
    Zhang JY; Kong YY; Wang QF; Yang YJ; Liu Z; Lin N; Ye DW; Dai B
    Asian J Androl; 2022; 24(1):50-55. PubMed ID: 34100390
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cell Cycle Progression Score, but Not Phosphatase and Tensin Homolog Loss, Is an Independent Prognostic Factor for Metastasis in Intermediate- and High-risk Prostate Cancer in Men Treated With and Without Salvage Radiotherapy.
    Trock BJ; Jing Y; Mabey B; Sangale Z; Lenz L; Haney N; Vidal I; Glavaris SA; Guner G; Ertunc O; Kulac I; Baena Del Valle JA; Jones T; Han M; Partin AW; Cohen T; Stone S; De Marzo AM
    J Urol; 2022 Dec; 208(6):1182-1193. PubMed ID: 36006048
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Benefit to neoadjuvant anti-human epidermal growth factor receptor 2 (HER2)-targeted therapies in HER2-positive primary breast cancer is independent of phosphatase and tensin homolog deleted from chromosome 10 (PTEN) status.
    Nuciforo PG; Aura C; Holmes E; Prudkin L; Jimenez J; Martinez P; Ameels H; de la Peña L; Ellis C; Eidtmann H; Piccart-Gebhart MJ; Scaltriti M; Baselga J
    Ann Oncol; 2015 Jul; 26(7):1494-500. PubMed ID: 25851628
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of the PTEN IVS4 (rs3830675) gene polymorphism with reduced risk of cancer: evidence from a meta-analysis.
    Mandal RK; Akhter N; Irshad M; Panda AK; Ali A; Haque S
    Asian Pac J Cancer Prev; 2015; 16(3):897-902. PubMed ID: 25735379
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of phosphatase and tensin homolog low and phosphatidylinositol 3-kinase catalytic subunit alpha gene mutations on outcome in human epidermal growth factor receptor 2-positive metastatic breast cancer patients treated with first-line lapatinib plus paclitaxel or paclitaxel alone.
    Xu B; Guan Z; Shen Z; Tong Z; Jiang Z; Yang J; DeSilvio M; Russo M; Leigh M; Ellis C
    Breast Cancer Res; 2014 Jul; 16(4):405. PubMed ID: 25056500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PTEN expression in endometrial hyperplasia and risk of cancer: a systematic review and meta-analysis.
    Raffone A; Travaglino A; Saccone G; Viggiani M; Giampaolino P; Insabato L; Mollo A; De Placido G; Zullo F
    Arch Gynecol Obstet; 2019 Jun; 299(6):1511-1524. PubMed ID: 30915635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of phosphatase and tensin homolog expression is associated with recurrence and poor prognosis in patients with pancreatic ductal adenocarcinoma.
    Foo WC; Rashid A; Wang H; Katz MH; Lee JE; Pisters PW; Wolff RA; Abbruzzese JL; Fleming JB; Wang H
    Hum Pathol; 2013 Jun; 44(6):1024-30. PubMed ID: 23260327
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phosphatase and tensin homolog protein may be linked to lymph node metastasis and tumor node metastasis staging in nonsmall cell lung cancer.
    Ji ZY; Li HF; Lei Y; Rao YW; Sun ML; Wang XW; Zhang YL
    J Cancer Res Ther; 2018; 14(Supplement):S138-S144. PubMed ID: 29578164
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retinoblastoma and phosphate and tensin homolog tumor suppressors: impact on ductal carcinoma in situ progression.
    Knudsen ES; Pajak TF; Qeenan M; McClendon AK; Armon BD; Schwartz GF; Witkiewicz AK
    J Natl Cancer Inst; 2012 Dec; 104(23):1825-36. PubMed ID: 23197489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNAs that regulate PTEN as potential biomarkers in colorectal cancer: a systematic review.
    Liu J; Ke F; Chen T; Zhou Q; Weng L; Tan J; Shen W; Li L; Zhou J; Xu C; Cheng H; Zhou J
    J Cancer Res Clin Oncol; 2020 Apr; 146(4):809-820. PubMed ID: 32146564
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PTEN as a predictive marker of response to conservative treatment in endometrial hyperplasia and early endometrial cancer. A systematic review and meta-analysis.
    Travaglino A; Raffone A; Saccone G; Insabato L; Mollo A; De Placido G; Zullo F
    Eur J Obstet Gynecol Reprod Biol; 2018 Dec; 231():104-110. PubMed ID: 30342311
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between PTEN Gene IVS4 polymorphism and risk of cancer: a meta-analysis.
    Sun L; Liu J; Yuan Q; Xing C; Yuan Y
    PLoS One; 2014; 9(6):e98851. PubMed ID: 24901890
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of phosphatase and tensin homolog protein expression is an independent poor prognostic marker in lung adenocarcinoma.
    Yanagawa N; Leduc C; Kohler D; Saieg MA; John T; Sykes J; Yoshimoto M; Pintilie M; Squire J; Shepherd FA; Tsao MS
    J Thorac Oncol; 2012 Oct; 7(10):1513-21. PubMed ID: 22982652
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Refining Prognosis in Localized Gastrointestinal Stromal Tumor: Clinical Significance of Phosphatase and Tensin Homolog Low Expression and Gene Loss.
    Feng X; Li H; Fourquet J; Brahmi M; Dufresne A; Meurgey A; Ray-Coquard I; Wang Q; Bollard J; Ducimetiere F; Chibon F; Blay JY
    JCO Precis Oncol; 2022 Aug; 6():e2200129. PubMed ID: 36001861
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of the phosphatase and tensin homolog status in predicting pathological complete response to neoadjuvant anti-HER2 therapies in HER2-positive primary breast cancer: A meta-analysis.
    Zhang C; Guo Y; Li J; Tian X; Duan X
    Medicine (Baltimore); 2019 Feb; 98(5):e14261. PubMed ID: 30702584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation Between Onco-suppressors PTEN and NM23 and Clinical Outcome in Patients With T1 Breast Cancer.
    Izzo L; Messineo D; DI Cello P; Nicolanti V; Sterpetti A; Izzo S; Izzo P
    In Vivo; 2021; 35(1):169-174. PubMed ID: 33402463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of PTEN expression with biochemical recurrence in prostate cancer: results based on previous reports.
    Xie H; Xie B; Liu C; Wang J; Xu Y
    Onco Targets Ther; 2017; 10():5089-5097. PubMed ID: 29123407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.